NCT02445534 Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy
| NCT ID | NCT02445534 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Medical Centre Ljubljana |
| Condition | Cardiomyopathy, Dilated |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2005-01 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2005-01 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Although several studies have demonstrated beneficial effects of stem cell therapy in patients with non-ischemic dilated cardiomyopathy, the long term benefits and predictors of response to therapy remain undefined. The aim of this registry is to pool long-term clinical data in patients with non-ischemic dilated cardiomyopathy undergoing autologous cell therapy in an attempt to better define predictors of response to such treatment.
Eligibility Criteria
Inclusion Criteria: * Patient inclusion criteria consisted of the following: age 18-65 years old, diagnosis of DCM according to the European Society of Cardiology position statement (9), optimal medical management for at least 6 months, left ventricular ejection fraction (LVEF) \<40%, and New York Heart Association functional Class III on stable medical therapy for at least 3 months before referral. Exclusion Criteria: * Patients with acute multi-organ failure or a history of hematologic neoplasms were not included.
Contact & Investigator
Bojan Vrtovec, MD, PhD
PRINCIPAL INVESTIGATOR
UMC Ljubljana
Frequently Asked Questions
Who can join the NCT02445534 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Cardiomyopathy, Dilated. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02445534 currently recruiting?
Yes, NCT02445534 is actively recruiting participants. Contact the research team at bojan.vrtovec@gmail.com for enrollment information.
Where is the NCT02445534 trial being conducted?
This trial is being conducted at Ljubljana, Slovenia.
Who is sponsoring the NCT02445534 clinical trial?
NCT02445534 is sponsored by University Medical Centre Ljubljana. The principal investigator is Bojan Vrtovec, MD, PhD at UMC Ljubljana. The trial plans to enroll 250 participants.